Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cholinesterase and Neurodegenerative Diseases
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the pharmacology and toxicology of cholinesterase inhibitors, particularly acetylcholinesterase and butyrylcholinesterase, in the context of neurodegenerative diseases such as Alzheimer's. It explores the development of multi-target-directed ligands, novel drug therapies, and the implications for cognitive deficits. The research also delves into the structure, function, and regulation of cholinesterases, as well as their potential roles in neuroprotection and neurorestoration.
166
Works
IDs:OpenAlex
How has Cholinesterase and Neurodegenerative Diseases's publication output changed over time?
ScholarIQpublication output · 2003–2022
Output grew0% over the shown period — from 1 works in 2003 to 1 in 2022.
1
1
1
2
1
1
1
1
1
1
2003200620072010201120122015201820202022
What are the most-cited papers on Cholinesterase and Neurodegenerative Diseases?
ScholarIQmost cited works
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Harald Hampel, M.‐Marsel Mesulam, A. Claudio Cuello, Martin R. Farlow, Ezio Giacobini, George T. Grossberg, Ara S. Khachaturian, Andrea Vergallo, Enrica Cavedo, Peter J. Snyder, Zaven S. Khachaturian
Brain. 20181,873 CitationsOPEN ACCESS
Current and Future Treatments in Alzheimer Disease: An Update
Konstantina G. Yiannopoulou, Sokratis G. Papageorgiou
S4210217671. 2020963 CitationsOPEN ACCESS
The cholinergic system and Parkinson disease
Nicolaas I. Bohnen, Roger L. Albin
Behavioural Brain Research. 2010562 CitationsOPEN ACCESS
Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease:
George T. Grossberg
S160239940. 2003378 CitationsOPEN ACCESS
The developmental multiplicity and isoenzyme status of cavian esterases
Roger S. Holmes, C.J. Masters
S4394906700. 1967239 Citations
Where is Cholinesterase and Neurodegenerative Diseases research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Cholinesterase and Neurodegenerative Diseases is open access?
ScholarIQopen access share
67%OPEN ACCESS
Gold
20%
Green
27%
Hybrid
0%
Bronze
20%
Closed
33%
Related on ScholarIQ
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Paper
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Paper
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Paper
Revising the definition of Alzheimer's disease: a new lexicon
Paper
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors
Paper
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Paper